130 related articles for article (PubMed ID: 8390098)
1. Imaging lung cancer with radiolabeled antibodies.
Breitz HB; Sullivan K; Nelp WB
Semin Nucl Med; 1993 Apr; 23(2):127-32. PubMed ID: 8390098
[TBL] [Abstract][Full Text] [Related]
2. Staging lung carcinoma with a Tc-99m labeled monoclonal antibody.
Vansant JP; Johnson DH; O'Donnell DM; Stewart JR; Sonin AH; McCook BM; Powers TA; Salk DJ; Frist WH; Sandler MP
Clin Nucl Med; 1992 Jun; 17(6):431-8. PubMed ID: 1319860
[TBL] [Abstract][Full Text] [Related]
3. Detection and staging of small cell lung carcinoma with a technetium-labeled monoclonal antibody. A comparison with standard staging methods.
Balaban EP; Walker BS; Cox JV; Bordlee RP; Salk D; Abrams PG; Sheehan RG; Frenkel EP
Clin Nucl Med; 1992 Jun; 17(6):439-45. PubMed ID: 1319861
[TBL] [Abstract][Full Text] [Related]
4. NR-LU-10 monoclonal antibody scanning. A helpful new adjunct to computed tomography in evaluating non-small-cell lung cancer.
Rusch V; Macapinlac H; Heelan R; Kramer E; Larson S; McCormack P; Burt M; Martini N; Ginsberg R
J Thorac Cardiovasc Surg; 1993 Aug; 106(2):200-4. PubMed ID: 8393504
[TBL] [Abstract][Full Text] [Related]
5. Radioimmunodetection of non-small cell lung cancer using technetium-99m-anticarcinoembryonic antigen IMMU-4 Fab' fragment. Preliminary results.
Kramer EL; Noz ME; Liebes L; Murthy S; Tiu S; Goldenberg DM
Cancer; 1994 Feb; 73(3 Suppl):890-5. PubMed ID: 8306275
[TBL] [Abstract][Full Text] [Related]
6. Radioimmunoimaging of non-small cell lung cancer with 111In- and 99mTc-labeled monoclonal anti-CEA-antibodies.
Kairemo KJ; Aronen HJ; Liewendahl K; Paavonen T; Heikkonen JJ; Virkkunen P; Mäki-Hokkonen H; Karonen SL; Brownell AL; Mäntylä MJ
Acta Oncol; 1993; 32(7-8):771-8. PubMed ID: 8305225
[TBL] [Abstract][Full Text] [Related]
7. Staging non-small cell carcinoma of the lung using technetium-99m-labeled monoclonal antibodies.
Friedman S; Sullivan K; Salk D; Nelp WB; Griep RJ; Johnson DH; Blend MJ; Aye R; Suppers V; Abrams PG
Hematol Oncol Clin North Am; 1990 Dec; 4(6):1069-78. PubMed ID: 1962776
[TBL] [Abstract][Full Text] [Related]
8. In-111 octreotide imaging in staging of small cell lung cancer.
Hochstenbag MM; Heidendal GA; Wouters EF; ten Velde GP
Clin Nucl Med; 1997 Dec; 22(12):811-6. PubMed ID: 9408640
[TBL] [Abstract][Full Text] [Related]
9. Technetium-99m monoclonal antibody fragment (Fab) scintigraphy in the evaluation of small cell lung cancer: a preliminary report.
Morris JF; Krishnamurthy S; Antonovic R; Duncan C; Turner FE; Krishnamurthy GT
Int J Rad Appl Instrum B; 1991; 18(6):613-20. PubMed ID: 1660451
[TBL] [Abstract][Full Text] [Related]
10. Radionuclide imaging of bone marrow metastases with a Tc-99m labeled monoclonal antibody to small cell lung carcinoma.
Balaban EP; Walker BS; Cox JV; Sein AA; Abrams PG; Salk D; Sheehan RG; Frenkel EP
Clin Nucl Med; 1991 Oct; 16(10):732-6. PubMed ID: 1660386
[TBL] [Abstract][Full Text] [Related]
11. The value of octreotide scintigraphy in patients with lung cancer.
Kwekkeboom DJ; Kho GS; Lamberts SW; Reubi JC; Laissue JA; Krenning EP
Eur J Nucl Med; 1994 Oct; 21(10):1106-13. PubMed ID: 7828621
[TBL] [Abstract][Full Text] [Related]
12. Two-step immunoscintigraphy for non-small-cell lung cancer staging using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer.
Vuillez JP; Moro D; Brichon PY; Rouvier E; Brambilla E; Barbet J; Peltier P; Meyer P; Sarrazin R; Brambilla C
J Nucl Med; 1997 Apr; 38(4):507-11. PubMed ID: 9098191
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of pentavalent Tc-99m DMSA scintigraphy in small cell and nonsmall cell lung cancers.
Atasever T; Gündoğdu C; Vural G; Kapucu LO; Karalezli A; Unlü M
Nuklearmedizin; 1997 Oct; 36(7):223-7. PubMed ID: 9394361
[TBL] [Abstract][Full Text] [Related]
14. Immunoscintigraphy of small-cell lung cancer: a study using technetium and indium labelled anti-carcinoembryonic antigen monoclonal antibody preparations.
Macmillan CH; Perkins AC; Wastie ML; Leach IH; Morgan DA
Br J Cancer; 1993 Jun; 67(6):1391-4. PubMed ID: 8390288
[TBL] [Abstract][Full Text] [Related]
15. Phase I and imaging trial of a monoclonal antibody directed against gastrin-releasing peptide in patients with lung cancer.
Chaudhry A; Carrasquillo JA; Avis IL; Shuke N; Reynolds JC; Bartholomew R; Larson SM; Cuttitta F; Johnson BE; Mulshine JL
Clin Cancer Res; 1999 Nov; 5(11):3385-93. PubMed ID: 10589749
[TBL] [Abstract][Full Text] [Related]
16. Immunoscintigraphy using 111in-labelled F(ab')2 fragments of anti-carcinoembryonic antigen (CEA) monoclonal antibody for staging of non-small cell lung carcinoma.
Vuillez JP; Moro D; Brambilla E; Brichon PY; Ferretti G; Saccavini JC; Brambilla C
Eur J Cancer; 1994; 30A(8):1089-92. PubMed ID: 7654435
[TBL] [Abstract][Full Text] [Related]
17. Comparison of FDG-PET findings of brain metastasis from non-small-cell lung cancer and small-cell lung cancer.
Lee HY; Chung JK; Jeong JM; Lee DS; Kim DG; Jung HW; Lee MC
Ann Nucl Med; 2008 May; 22(4):281-6. PubMed ID: 18535878
[TBL] [Abstract][Full Text] [Related]
18. Indium-111 pentetreotide in the diagnostic work-up of patients with bronchogenic carcinoma.
Kirsch CM; von Pawel J; Grau I; Tatsch K
Eur J Nucl Med; 1994 Dec; 21(12):1318-25. PubMed ID: 7875170
[TBL] [Abstract][Full Text] [Related]
19. Radioimmunodetection of human small cell lung carcinoma xenografts in the nude rat using 111in-labelled monoclonal antibody MOC-31.
de Jonge MW; Kosterink JG; Bin YY; Bulte JW; Kengen RA; Piers DA; The TH; de Leij L
Eur J Cancer; 1993; 29A(13):1885-90. PubMed ID: 8260247
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and scintigraphy of indium-111-DTPA-MOC-31 in small-cell lung carcinoma.
Kosterink JG; de Jonge MW; Smit EF; Piers DA; Kengen RA; Postmus PE; Shochat D; Groen HJ; The HT; de Leij L
J Nucl Med; 1995 Dec; 36(12):2356-62. PubMed ID: 8523132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]